Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Alexandria Real Estate Equities, Inc. (NYSE:ARE), raising its ownership by 11.5% in the first quarter. According to its most recent 13F filing with the Securities and Exchange Commission (SEC), the institutional investor now owns 378,712 shares of the real estate investment trust, having purchased an additional 39,013 shares during the period. As of the filing, Mitsubishi UFJ owned 0.22% of Alexandria Real Estate Equities, valued at $35,035,000.\n\nAlexandria Real Estate Equities has a market capitalization of $12.83 billion, with shares trading at $74.20, down from a 12-month high of $125.63. The company reported an earnings per share (EPS) of $2.33 for the last quarter, exceeding the consensus estimate of $2.29 by $0.04. However, revenue declined 0.6% year-over-year to $737.28 million, compared to analysts' expectations of $748.02 million. The firm recorded a negative net margin of 0.33% and a negative return on equity of 0.05%.\n\nThe company recently paid a quarterly dividend of $1.32, which amounts to an annualized dividend of $5.28 and yields 7.1%. The payout ratio is currently -4,061.54%. The stock has a P/E ratio of -570.78, a P/E/G ratio of 6.25, and a beta of 1.24. Its fifty-day moving average is $75.42, and its 200-day moving average is $82.81. The company has a quick ratio and current ratio of 0.23 each, and a debt-to-equity ratio of 0.61.\n\nWall Street analysts have issued various reports on Alexandria Real Estate Equities. Citigroup reduced its target price from $110.00 to $74.00, JMP Securities reaffirmed a 'market outperform' rating with a $130.00 target, Royal Bank of Canada lowered its price objective to $98.00 with a 'sector perform' rating, Mizuho decreased its target from $121.00 to $91.00, and Wedbush reduced its target to $76.00 with a 'neutral' rating. Ten analysts have assigned a 'hold' rating, and two have issued a 'buy' rating. The average rating is 'Hold' with a consensus price target of $97.17.\n\nAlexandria Real Estate Equities is a best-in-class, mission-driven life science REIT that owns, operates, and develops collaborative life science, agtech, and advanced technology mega campuses in key innovation clusters such as Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and the Research Triangle. The company has been a pioneer in the life science real estate niche since its founding in 1994.\n\nOther institutional investors have also adjusted their positions: Charles Schwab Investment Management Inc. raised its holdings by 2.6%, now owning 2,530,184 shares worth $234,067,000; ASR Vermogensbeheer N.V. acquired a stake worth $1,261,000; American Assets Investment Management LLC bought a stake worth $569,000; IQ EQ FUND MANAGEMENT IRELAND Ltd increased its holdings by 32.1% to 15,735 shares worth $1,456,000; and Avalon Trust Co acquired a stake valued at approximately $32,000. Institutional investors collectively own 96.54% of the company's stock.\n\nThe company last reported earnings on July 21, 2025. Sell-side analysts anticipate a full-year EPS of $9.32. MarketBeat has identified that top analysts are not currently recommending Alexandria Real Estate Equities, suggesting it may be overlooked despite its fundamentals.

Alexandria Real Estate Equities, Inc. (NYSE:ARE) Stake Raised by Mitsubishi UFJ Asset Management Co. Ltd.

Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Alexandria Real Estate Equities, Inc. (ARE) by 11.5% in the first quarter, now owning 378,712 shares valued at $35.04 million, representing 0.22% of the company. Alexandria Real Estate Equities reported an EPS of $2.33, exceeding expectations, but saw a 0.6% year-over-year revenue decline and negative net margin and return on equity. The company paid a $1.32 quarterly dividend, resulting in a 7.1% yield and a negative payout ratio of -4,061.54%. Its market cap is $12.83 billion, trading at $74.20, down from a 12-month high of $125.63. Wall Street analysts have adjusted their target prices, with Citigroup lowering its target to $74.00, JMP Securities maintaining a 'market outperform' rating with a $130.00 target, and others reducing their estimates. The company operates life science, agtech, and advanced technology campuses in key innovation hubs including Greater Boston, San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and the Research Triangle. Institutional investors collectively own 96.54% of the company's shares.